Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Barrett Esophagus
Research findings from Brigham and Women's Hospital update understanding of barrett esophagus
May 19th, 2009
According to recent research from the United States, "The rate Of Occult adenocarcinoma at esophagectomy in patients with Barrett's esophagus (BE) and high-grade dysplasia (HGD) has been reported to he approximately 40%. Recently, it has been Suggested that this risk may he overestimated." "Our purpose was to determine the rate Of submucosal invasive adenocarcinoma in patients undergoing esophagectomy for BE after biopsy diagnosis of HGD or intramucosal carcinoma (IMC). A secondary aim was to identify clinical risk factors for submucosal invasive adenocarcinoma in these patients. A retrospective study. Tertiary referral center. All patients with preoperative BE with HGD...
Source: Cancer Weekly (2009-05-19)
|
